Moderna Inc (MRNA)

Moderna Inc Aktie (MRNA) Neueste Nachrichten

Oct 29, 2026

GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth? - Zacks Investment Research

Oct 29, 2026

Oct 29, 2026

MRK Q3 Earnings & Sales Beat Estimates, '26 EPS View Raised, Stock Up - Zacks Investment Research

Oct 29, 2026

Oct 29, 2026

Will Moderna Soar on Nov. 6? - The Motley Fool

Oct 29, 2026

Oct 28, 2026

Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp Volatility - The Motley Fool

Oct 28, 2026

Oct 27, 2026

Moderna, Inc. (MRNA) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 27, 2026

Oct 26, 2026

Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy? - The Motley Fool

Oct 26, 2026

Oct 26, 2026

Breakfast News: Science Strikes Back at Cancer - The Motley Fool

Oct 26, 2026

Oct 26, 2026

Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Zacks Investment Research

Oct 26, 2026

Oct 25, 2026

VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? - The Motley Fool

Oct 25, 2026

Oct 24, 2026

Breakfast News: A Conversation With Moderna’s CEO - The Motley Fool

Oct 24, 2026

Oct 23, 2026

American Tower (AMT) jumps 8% at the open, towering over a 385-stock board - 24/7 Wall St.

Oct 23, 2026

Oct 23, 2026

Moderna’s Stock Just Stumbled. Is It a Buy on the Dip? - The Motley Fool

Oct 23, 2026

Oct 23, 2026

Moderna Wins Top Employer Status - Baystreet.ca

Oct 23, 2026

Oct 23, 2026

Capital Group Global Growth (CGGO) Buys $121.1 Million More Moderna on Oct. 21 - Yahoo Finance

Oct 23, 2026

Oct 23, 2026

Why Healthcare ETFs Are Hovering Around One-Year Highs - Zacks Investment Research

Oct 23, 2026

Oct 22, 2026

Chubb Breaks to a New 52-Week High at $363.95 - 24/7 Wall St.

Oct 22, 2026

Oct 22, 2026

Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports - The Motley Fool

Oct 22, 2026

Oct 22, 2026

Moderna Sheds $12 Billion in a Single Session After a 14% Drop - 24/7 Wall St.

Oct 22, 2026

Oct 22, 2026

Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? - The Motley Fool

Oct 22, 2026

Oct 21, 2026

Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 - The Motley Fool

Oct 21, 2026

Oct 21, 2026

Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice - The Motley Fool

Oct 21, 2026

Oct 20, 2026

Moderna MRNA Breaks to a New 52-Week High at $242.08 - 24/7 Wall St.

Oct 20, 2026

Oct 20, 2026

Merck & (MRK) Stock Price, News & Analysis - 24/7 Wall St.

Oct 20, 2026

Oct 18, 2026

Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? - The Motley Fool

Oct 18, 2026

Oct 18, 2026

Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. - The Motley Fool

Oct 18, 2026

Oct 18, 2026

Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027? - The Motley Fool

Oct 18, 2026

Oct 17, 2026

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline - The Motley Fool

Oct 17, 2026

Oct 17, 2026

The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going - The Motley Fool

Oct 17, 2026

Oct 17, 2026

Form 4 Moderna Inc: Stephen Hoge (President) For: 14 October By Investing.com - Investing.com Australia

Oct 17, 2026

Oct 17, 2026

Form 4 Moderna Inc: Stephen Hoge (President) For: 14 October By Investing.com - Investing.com Nigeria

Oct 17, 2026

Oct 17, 2026

Form 4 Moderna Inc: Stephen Hoge (President) For: 14 October By Investing.com - Investing.com UK

Oct 17, 2026

Oct 16, 2026

Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy? - The Motley Fool

Oct 16, 2026

Oct 15, 2026

Moderna Executive Stephen Hoge Announces Intent to Sell 39,145 Shares Under Rule 144 - Kalkine Media

Oct 15, 2026

Oct 13, 2026

MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell? - Zacks Investment Research

Oct 13, 2026

Oct 13, 2026

Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 13, 2026

Oct 12, 2026

Here's Why Moderna (MRNA) Fell More Than Broader Market - Zacks Investment Research

Oct 12, 2026

Oct 12, 2026

Tempus AI Expands Strategic Collaborations to Drive Future Growth - Zacks Investment Research

Oct 12, 2026

Oct 11, 2026

Lori Trahan Stock Trades and Disclosures - TechGraph

Oct 11, 2026

Oct 10, 2026

Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? - The Motley Fool

Oct 10, 2026

Oct 10, 2026

Daniel S Sullivan Stock Trades and Disclosures - TechGraph

Oct 10, 2026

Oct 09, 2026

Moderna surges 12.6% after hours, adding roughly $11 billion in value - 24/7 Wall St.

Oct 09, 2026

Oct 08, 2026

Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock? - Zacks Investment Research

Oct 08, 2026

Oct 08, 2026

Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now? - Zacks Investment Research

Oct 08, 2026

Oct 08, 2026

Form 4 Moderna Inc For: 7 October By Investing.com - Investing.com India

Oct 08, 2026

Oct 08, 2026

Frank Baker joins IBM's board, bringing a private equity edge to a $213.5 billion tech giant - 24/7 Wall St.

Oct 08, 2026

Oct 07, 2026

Form 4 Moderna Inc For: 7 October By Investing.com - Investing.com Canada

Oct 07, 2026

Oct 07, 2026

Form 4 Moderna Inc For: 7 October By Investing.com - Investing.com UK

Oct 07, 2026

Oct 07, 2026

Moderna (MRNA) CFO has 704 shares withheld for taxes after converting a stock grant. - Stock Titan

Oct 07, 2026

Oct 06, 2026

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity? - Zacks Investment Research

Oct 06, 2026

Oct 06, 2026

Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety - Benzinga

Oct 06, 2026